{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:09:49Z","timestamp":1778872189476,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Routine provider-performed physical examinations remain a standard element of breast cancer survivorship despite increasing evidence that diagnostic yield is limited. With growing survivorship populations and mounting demands on oncology services, reassessment of the value of this practice is warranted. This study sought to evaluate the diagnostic yield and prognostic relevance of surveillance physical exams.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review was conducted of women with breast cancer treated between January 2019 and December 2023 at a single tertiary center. Surgical oncology survivorship visits &gt;90 days postoperatively were analyzed. Recurrence events were categorized by initial detection modality: provider-performed physical examination, patient-reported, screening imaging, or symptom-prompted non-breast imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 3337 patients, 131 recurrences (3.9%) occurred after a median of 20 months. Patients collectively attended 12,840 survivorship visits; only eight recurrences (6.1% of all recurrences; 0.06% of examinations) were first detected by physical examination. By comparison, 32 (24.4%) were patient-reported, 38 (29.0%) were detected on screening imaging, and 53 (40.5%) were identified by non-breast diagnostic imaging. When stratified by detection method, exam-detected recurrences were evenly divided between locoregional and combined locoregional\/distant disease, whereas patient-reported and screening-detected recurrences were predominantly locoregional, at 72% and 92%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Breast and chest wall examinations accounted for a small proportion of recurrence detections despite thousands of survivorship visits annually. Most clinically meaningful recurrences were identified by imaging or patient self-report. These findings support survivorship strategies that prioritize imaging adherence and structured symptom assessment, with less emphasis on routine physical examination as a primary detection modality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19227-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:53:56Z","timestamp":1770918836000},"page":"5502-5512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance"],"prefix":"10.1245","volume":"33","author":[{"given":"Anna","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Terrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bishay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Paul","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"11","key":"19227_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.6004\/jnccn.2025.0053","volume":"23","author":"WJ Gradishar","year":"2025","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. NCCN guidelines\u00ae insights: breast cancer, version 5. 2025. J Natl Compr Canc Netw. 2025;23(11):426\u201336. https:\/\/doi.org\/10.6004\/jnccn.2025.0053.","journal-title":"J Natl Compr Canc Netw."},{"issue":"Suppl 6","key":"19227_CR2","doi-asserted-by":"publisher","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","volume":"24","author":"E Senkus","year":"2013","unstructured":"Senkus E, Kyriakides S, Penault-Llorca F, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi7\u201323. https:\/\/doi.org\/10.1093\/annonc\/mdt284.","journal-title":"Ann Oncol."},{"issue":"6","key":"19227_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","volume":"34","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, et al. American cancer society\/american society of clinical oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611\u201335. https:\/\/doi.org\/10.1200\/JCO.2015.64.3809.","journal-title":"J Clin Oncol."},{"issue":"12","key":"19227_CR4","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/sj.bjc.6604065","volume":"97","author":"DA Montgomery","year":"2007","unstructured":"Montgomery DA, Krupa K, Cooke TG. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer. 2007;97(12):1632\u201341. https:\/\/doi.org\/10.1038\/sj.bjc.6604065.","journal-title":"Br J Cancer."},{"issue":"5","key":"19227_CR5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s11764-022-01178-z","volume":"17","author":"JW Ankersmid","year":"2023","unstructured":"Ankersmid JW, Drossaert CHC, van Riet YEA, Strobbe LJA, Siesling S, Santeon VBHC. Breast cancer group. Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance. J Cancer Surviv. 2023;17(5):1471\u20139. https:\/\/doi.org\/10.1007\/s11764-022-01178-z.","journal-title":"J Cancer Surviv."},{"key":"19227_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2023.03.004","volume":"69","author":"AA Beltran-Bless","year":"2023","unstructured":"Beltran-Bless AA, Alshamsan B, Alzahrani MJ, et al. Regularly scheduled physical examinations and the detection of breast cancer recurrences. Breast. 2023;69:274\u201380. https:\/\/doi.org\/10.1016\/j.breast.2023.03.004.","journal-title":"Breast."},{"issue":"1","key":"19227_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-025-07793-5","volume":"214","author":"AA Beltran-Bless","year":"2025","unstructured":"Beltran-Bless AA, de Lima MI, Clemons L, et al. Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences? Breast Cancer Res Treat. 2025;214(1):59\u201368. https:\/\/doi.org\/10.1007\/s10549-025-07793-5.","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"19227_CR8","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/j.clbc.2024.12.014","volume":"25","author":"LTH Godding","year":"2025","unstructured":"Godding LTH, Dekker-Klaassen A, Volders JH, et al. The added value of physical examination for breast cancer recurrence detection in women: a systematic review. Clin Breast Cancer. 2025;25(4):e383-e393.e2. https:\/\/doi.org\/10.1016\/j.clbc.2024.12.014.","journal-title":"Clin Breast Cancer."},{"key":"19227_CR9","unstructured":"American Cancer Society:\u00a0Breast cancer facts & figures 2024-2025. Atlanta: American Cancer Society, Inc. 2024. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/2024\/breast-cancer-facts-and-figures-2024.pdf."},{"issue":"1","key":"19227_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"19227_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1200\/OP.20.00600","volume":"17","author":"YT Shih","year":"2021","unstructured":"Shih YT, Kim B, Halpern MT. State of physician and pharmacist oncology workforce in the United States in 2019. JCO Oncol Pract. 2021;17(1):e1\u201310. https:\/\/doi.org\/10.1200\/OP.20.00600.","journal-title":"JCO Oncol Pract."},{"key":"19227_CR12","doi-asserted-by":"publisher","unstructured":"2022 Snapshot: state of the oncology workforce in America.\u00a0JCO Oncol Pract. 2022;18(5):396. https:\/\/doi.org\/10.1200\/OP.22.00168.","DOI":"10.1200\/OP.22.00168"},{"issue":"12","key":"19227_CR13","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/sj.bjc.6603815","volume":"96","author":"DA Montgomery","year":"2007","unstructured":"Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer. 2007;96(12):1802\u20137. https:\/\/doi.org\/10.1038\/sj.bjc.6603815.","journal-title":"Br J Cancer."},{"issue":"11","key":"19227_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/sj.bjc.6603771","volume":"96","author":"DA Montgomery","year":"2007","unstructured":"Montgomery DA, Krupa K, Cooke TG. Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer. 2007;96(11):1625\u201332. https:\/\/doi.org\/10.1038\/sj.bjc.6603771.","journal-title":"Br J Cancer."},{"key":"19227_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejca.2018.07.124","volume":"102","author":"MC van Maaren","year":"2018","unstructured":"van Maaren MC, Strobbe LJA, Smidt ML, Moossdorff M, Poortmans PMP, Siesling S. Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years. Eur J Cancer. 2018;102:82\u201394. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.124.","journal-title":"Eur J Cancer."},{"issue":"1","key":"19227_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12885-019-5710-5","volume":"19","author":"B Holleczek","year":"2019","unstructured":"Holleczek B, Stegmaier C, Radosa JC, Solomayer EF, Brenner H. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany. BMC Cancer. 2019;19(1):520. https:\/\/doi.org\/10.1186\/s12885-019-5710-5.","journal-title":"BMC Cancer."},{"issue":"3","key":"19227_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-017-4340-3","volume":"165","author":"YM Geurts","year":"2017","unstructured":"Geurts YM, Witteveen A, Bretveld R, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res Treat. 2017;165(3):709\u201320. https:\/\/doi.org\/10.1007\/s10549-017-4340-3.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"19227_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/OP.20.00199","volume":"16","author":"R Liu","year":"2020","unstructured":"Liu R, Sundaresan T, Reed ME, Trosman JR, Weldon CB, Kolevska T. Telehealth in oncology during the COVID-19 Outbreak: bringing the house call back virtually. JCO Oncol Pract. 2020;16(6):289\u201393. https:\/\/doi.org\/10.1200\/OP.20.00199.","journal-title":"JCO Oncol Pract."},{"key":"19227_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1200\/EDBK_238267","volume":"39","author":"CM Alfano","year":"2019","unstructured":"Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK. Building personalized cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia. Am Soc Clin Oncol Educ Book. 2019;39:625\u201339. https:\/\/doi.org\/10.1200\/EDBK_238267.","journal-title":"Am Soc Clin Oncol Educ Book."},{"issue":"17","key":"19227_CR20","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1200\/JCO.23.01447","volume":"42","author":"L Saltb\u00e6k","year":"2024","unstructured":"Saltb\u00e6k L, Bidstrup PE, Karlsen RV, et al. Nurse-led individualized follow-up versus regular physician-led visits after early breast cancer (MyHealth): a phase III randomized. Controlled Trial J Clin Oncol. 2024;42(17):2038\u201349. https:\/\/doi.org\/10.1200\/JCO.23.01447.","journal-title":"Controlled Trial. J Clin Oncol."},{"issue":"6","key":"19227_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.17873","volume":"7","author":"I Graetz","year":"2024","unstructured":"Graetz I, Hu X, Kocak M, et al. Remote monitoring app for endocrine therapy adherence among patients with early-stage breast cancer: a randomized clinical trial. JAMA Netw Open. 2024;7(6):e2417873. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.17873.","journal-title":"JAMA Netw Open."},{"issue":"4","key":"19227_CR22","doi-asserted-by":"publisher","DOI":"10.2196\/38088","volume":"8","author":"JW Ankersmid","year":"2022","unstructured":"Ankersmid JW, Siesling S, Strobbe LJA, et al. Supporting shared decision-making about surveillance after breast cancer with personalized recurrence risk calculations: development of a patient decision aid using the international patient decision aids standards development process in combination with a mixed methods design. JMIR Cancer. 2022;8(4):e38088. https:\/\/doi.org\/10.2196\/38088.","journal-title":"JMIR Cancer."},{"key":"19227_CR23","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.21.00160","volume":"6","author":"E Neeman","year":"2022","unstructured":"Neeman E, Lyon L, Sun H, et al. Future of teleoncology: trends and disparities in telehealth and secure message utilization in the COVID-19 era. JCO Clin Cancer Inform. 2022;6:e2100160. https:\/\/doi.org\/10.1200\/CCI.21.00160.","journal-title":"JCO Clin Cancer Inform."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19227-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:27:59Z","timestamp":1778869679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19227-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["19227"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19227-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}